Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer
- 1 July 2013
- journal article
- Published by Future Medicine Ltd in Future Oncology
- Vol. 9 (7), 921-923
- https://doi.org/10.2217/fon.13.80
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Thyroid lobectomy for treatment of well differentiated intrathyroid malignancySurgery, 2012
- The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancerSurgery, 2011
- Use of Radioactive Iodine for Thyroid CancerJAMA, 2011
- Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancerHead & Neck, 2010
- Mild Decreases in White Blood Cell and Platelet Counts Are Present One Year After Radioactive Iodine Remnant AblationThyroid®, 2009
- Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine AblationJournal of Nuclear Medicine, 2009
- Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysisThyroid®, 2009
- Clinical Predictors of Quality of Life in Patients With Initial Differentiated Thyroid CancersJAMA Otolaryngology–Head & Neck Surgery, 2009
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994
- RADIOACTIVE IODINE THERAPYJournal of the American Medical Association, 1946